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Vitamin D receptors have been identiﬁed in skeletal muscle; and symptoms of vitamin D deﬁciency include muscle weakness and
pain. Moreover, increased serum 25-hydroxyvitamin D (25(OH)D) concentrations have been associated with improved muscle
function. To further clarify the importance of vitamin D to muscle, we examined the association between vitamin D status and
exercise-induced muscle pain and weakness in healthy people. Muscle damage to the elbow ﬂexors was induced with eccentric
exercise (EE) in 48 individuals (22.5 ± 3.2yrs). Muscle pain ratings following unloaded movement and peak isometric force (IF)
were collected before EE and for 4 days post-EE. Linear regression was used to determine if serum 25(OH)D was a predictor of
any outcome. In males,R2-values from 0.48 to 1.00. R2 for IF ranged from 0 to 0.02 and P-values from 0.48 to 1.00. In females, R2
for pain ratings ranged from 0.01 to 0.11 and P-values from 0.14 to 0.59. R2 for IF ranged from 0 to 0.04 and P-values from 0.41
to 0.90. In conclusion,vitamin D status did not predict musclepain or strength after EE-induced muscledamage in young healthy
men and women.
1.Introduction
The prevalence of vitamin D insuﬃciency in the US, as
measured by serum concentrations of 25-hydroxyvitamin
D (25(OH)D), has been classiﬁed as an “epidemic”—
aﬀecting approximately 25%–35% of the adult population
[1]. Globally, the prevalence is reported to be even higher,
aﬀecting up to 80% of high-risk populations such as dark-
skinned individuals or those with limited/no sun exposure
[2].
T h ei m p o r t a n c eo fv i t a m i nDi ns k e l e t a lm u s c l e
(SkM) function has been demonstrated by the presence
of the vitamin D receptor (VDR) in both the nucleus
and plasma membrane of human SkM ﬁbers [3]a n d
by defective muscle development and function in VDR
knockout mice [4]. The biologically active form of vitamin
D, 1,25-dihydroxyvitamin D (1,25(OH)2D), acts through
genomic control to regulate protein synthesis in muscle cells.
Rapid responses to 1,25(OH)2Di nS k Ma r em e d i a t e db y
the membrane-bound VDR, which triggers several key cell
signal cascades, especially those involved in calcium ﬂux and
mitogenic processes [5].
Reports of severe adult-onset vitamin D deﬁciency,
knownasosteomalacicmyopathy,providedtheﬁrstevidence
of a link between vitamin D and SkM in humans. In
this condition of soft, undermineralized bone, often the
ﬁrst observed symptoms are muscle weakness and pain
[6]. Remarkably, muscle weakness can even exist during
deﬁciency without biochemical signs of bone involvement
[7]. Several large cross-sectional studies have described
diminished muscle strength and physical performance in
individuals with lower serum 25(OH)D [8–10]. Moreover,
studies have shown that when vitamin D supplementation is
suﬃcient to raise serum 25(OH)Dconcentrations, outcomes
related to muscle function improve risk of falls, relative size
and number oftypeII muscleﬁbers, and lowerlimb and grip
strength [11, 12].2 Journal of Nutrition and Metabolism
Vitamin D deﬁciency is also associated with persistent
musculoskeletal pain. Ninety-three percent of ambulatory
outpatients with chronic, nonspeciﬁc musculoskeletal pain
were found to be deﬁcient in vitamin D [13]. In a separate
reportinvolvingchroniclowbackpainpatients,83%hadlow
vitamin D status; following vitamin D therapy, 95% of these
patients showed improvement in their symptoms [14].
To further clarify the importance ofvitamin Dto muscle,
the present study examined the association of vitamin D
status and exercise-induced muscle pain and weakness in
healthy people. The muscle pain and weakness were induced
in the elbow ﬂexors by vigorous eccentric exercise. We tested
the hypothesis that lower serum concentrations of 25(OH)D
are associated with greater muscle weakness and pain after
eccentric exercise in young, healthy volunteers.
2.Materialsand Methods
2.1. Participant Recruitment. The relationship between vita-
min D status and muscle pain/strength after eccentric
exercise (EE) was explored using a secondary analysis of
data collected from an investigation of exercise-induced
muscle damage that was designed to examine sensitization
to pressure and activity after lengthening contractions [15].
The study wasapprovedbytheUniversity ofMissouri Health
Sciences Institutional Review Board; all participants gave
informed written consent prior to data collection.
Twenty-seven males and 21 females, aged 18 to 45 years,
were recruited by public advertisement from the University
of Missouri Columbia campus and community. Exclusion
criteria were arm strength training two to three times per
week within the previous six months; injury to the shoulder,
arm, wrist, orhand in theprevioussix months; consumption
of any performance enhancing drugs or medications that
couldaﬀectpainperceptionorresponse toeccentricexercise;
illness within one week of participation; chronic medical
conditions aﬀecting pain perception; hypercholesterolemia
or thyroid dysfunction; history of heat illness, kidney or liver
dysfunction, cardiac conditio n ,o rm u s c l ed i s e a s e ;f a m i l y
history of muscle disease or sickle cell disease; allergy to
aspirin or nonsteroidal anti-inﬂammatory medications; lack
of regular menstruation for females.
Prior to the initial two sessions, participants were
instructed to refrain from smoking for three hours, alcohol
for 12 hours, and taking pain medication for 24 hours. After
the initial session, ﬁve more sessions were conducted, all of
which were held during the follicular phase of the menstrual
cycle for females. Throughout the ﬁve subsequent sessions,
self-carebehaviorssuchasmassage,consumptionofanypain
relieving medications, and the application of heat, cold or
pain relieving cream, were prohibited.
2.2. Study Protocol and Assessments. During the initial
session, descriptive data were collected by questionnaire,
including sex, race, ethnicity, date of last menstrual period,
and medications, including birth control, and dietary sup-
plements consumed. Height and weight were measured.
Baseline isometric strength of the nondominant elbow
ﬂ e x o r sw a sm e a s u r e da sp e a kf o r c e ,u s i n gt h eB i o d e xS y s t e m
3( B i o d e xM e d i c a lS y s t e m s ,S h i r l e y ,N Y ) .F i v em a x i m a l
voluntaryisometric contractions atelbow ﬂexionof 90◦ were
performed, each lasting 5 seconds and separated by a 2-
minute rest.
Baseline pain ratings for the nondominant arm were
obtained during completeﬂexion and extension ofthe elbow
in supination. Numerical ratings for both pain intensity
and pain unpleasantness were recorded, using a validated
scale of 0–100 [16], in which 0 indicated “no pain” or “not
at all unpleasant” and 100 meant the “most intense pain
sensationimaginable”or“mostunpleasantpainimaginable,”
respectively.
At least 24 hours after the ﬁrst session, the volunteers
returned for a second session during which muscle strength
and pain measures were repeated, followed by eccentric
strength testing of the nondominant arm [17]. Then an
EE protocol was completed that consisted of 3 sets of 12
repetitions with strong verbal encouragement to produce
75% of maximal eccentric peak torque on each repetition.
A two-minute rest period separated the sets. One hour later,
and then daily for 4 days, participants returned for muscle
pain and isometric strength measurements. This induced
muscle pain has been documented to last up to 10 days [18],
while the muscle weakness has been reported to last over 30
days in some participants [19].
2.3. Vitamin D Status. Serum 25(OH)D was assayed in
serum two days after EE using a commercially available
radioimmunoassay (DiaSorin, Stillwater, MN; intra-assay
CV = 10.8%).
2.4. Data Analysis. Linear regression ofall outcomevariables
against serum 25(OH)D was carried out using the statistical
package “R”( The R Foundation for Statistical Computing,
2.2.1, 2005). There is evidence of sex-speciﬁc variations
in muscle strength, (as well as other phenotypic traits),
according to speciﬁc VDR polymorphisms [20, 21]. Thus,
data for men and women were analyzed separately. A P
value .05 was considered to be statistically signiﬁcant for all
analyses.
3.Results
Participant characteristics and serum 25(OH)D are listed in
Table 1. According to the recommended vitamin D status
classiﬁcations of Grant and Holick [22]. 10.4% of all subjects
were deﬁcient (<50nmol/L), 54.2% were insuﬃcient (50–
80nmol/L), and 33.3% were suﬃcient (80–250nmol/L);
one male participant had a very high 25(OH)D serum
concentration (269.5nmol/L).
As expected, pain measures for both sexes increased
after EE, peaking 2 days after EE. Figure 1 depicts the
time course for pain intensity during unloaded ﬂexion and
extension. This plot is representative of the progression of
painunpleasantness aswell. Alsoasexpected,peaktorquefor
both sexes decreased after EE, reaching a nadir at 1 hour forJournal of Nutrition and Metabolism 3
Table 1: Participant characteristics (values are means ± SD).
All Male Female
N 48 27 21
Age (y) 22.5 ± 3.2 22.5 ± 3.4 22.6 ± 3.2
BMI (kg/m2) 25.8 ± 6.8 25.8 ± 4.9 25.9 ± 8.8
Nonhispanic white
(%)
83.3% 85.2% 81.0%
Supplement usea 211
Serum 25(OH)D,
(nmol/L)b 77.4 ± 36.1 78.15 ± 43.4 76.5 ± 24.7
aNumber of participants using supplements with plausible inﬂuence on
outcomes, for example, omega-3 fatty acid.
bMeasures of 25-hydroxyvitamin D were obtained from serum drawn
during Session 4, ∼48-hour posteccentric exercise, representing a single
measurement during the study. Serum 25(OH)D concentration ranges for
all,males,and femaleswere 19.7–269.3,32.4–269.5,and 19.7–111.3nmol/L,
respectively.
females and 2 days for males, and then gradually increasing,
as shown in Figure 2.
Linear regression of pain measures against serum
25(OH)D showed that vitamin D status did not predict
either of the pain outcomes for males or females, at any
time after EE. Additionally, vitamin D status did not predict
muscle strength expressed as percent of baseline strength.
Table 2 lists the results of these regression analyses. To better
illustrate this, we plotted (Figure 3) the mean pain intensity
rating (scale 0–100) during unloaded movement through
full range of motion of the elbow versus serum 25OHD
concentrations in female participants (the plot for males was
not diﬀerent).
4.Discussion
To further clarify the importance of vitamin D to muscle,
this study examined the association of vitamin D status
and exercise-induced muscle pain and weakness in healthy
people. We tested the hypothesis that lower serum con-
centrations of 25(OH)D are associated with greater muscle
weakness and pain after eccentric exercise in young, healthy
volunteers. Our results, however, did not conﬁrm this
hypothesis.
The pattern of elbow ﬂexor strength after eccentric
exercisewasasexpected,withadecreaseinstrengthinthe48-
hourperiodaftereccentrics,followedbyagradualincreasein
torque values. Vitamin D status did not predict this outcome
at any time point after eccentric exercise, nor did it predict
baseline strength. Although the basis for the lack of eﬀects
observed in our study is unknown, we oﬀer two possible
explanations: age- or genotype-related diﬀerences in muscle
VDR,orvitamin Dthreshold eﬀectsinmusclesmay be lower
than other tissues.
The number of VDRs present in skeletal muscle declines
with age [23]; thus, strength in young adults, such as
the participants in this study, may be less sensitive to
vitamin D insuﬃciency because of the abundance of VDR
in their myoﬁbers. Moreover, speciﬁc VDR polymorphisms
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Figure 1: Progress of pain intensity throughout the study period.
Mean (±SE)ofpainintensityratings(scale0–100)duringunloaded
movementthrough fullrangeofmotionoftheelbow.Timeafter EE
refers to time elapsed after the eccentric exercise protocol, during
which muscledamage was induced. Pain intensity rating was oneof
two distinct pain outcomes. The other, pain unpleasantness rating,
followed a similar pattern following the eccentric exercise protocol.
Males:N = 26 (baseline), N = 27(allother times);females:N = 20
(4 days), N = 21 (all other times).
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Figure 2: Progress of muscle strength throughout the study period.
Mean (±SE) peak torque for males and females during isometric
strength testing of the elbow ﬂexors. Time after EE refers to time
elapsed after the eccentric exercise protocol, during which muscle
damage was induced. N m = Newton-meters. Males: N = 25 (4
days), N = 26 (baseline, 1 hour, 2 and 3 days), N = 27 (1 day);
females: N = 20 (4 days), N = 21 (all other times).4 Journal of Nutrition and Metabolism
Table 2: Regression analyses of serum 25OHD concentrations versus pain and strength outcomes in participants two days after undergoing
the eccentric exercise protocol.
Males Females
Outcome Range of R2 values Range of P valuesa Range of R2 values Range of P valuesa
Isometric peak torque 0–0.02 (25–27)b 0.48–0.83 0–0.04 (20-21) 0.41–0.90
Isometric peak torque as % baseline 0–0.03 (25–27) 0.43–0.87 0–0.12 (20-21) 0.12–0.97
Pain intensity during movement 0–0.02 (26-27) 0.42–0.95 0.02–0.05 (20-21) 0.14–0.59
Pain unpleasantness during movement 0–0.01 (26-27) 0.61–0.88 0.02–0.07 (21) 0.23–0.65
aNo regressions were statisticallysigniﬁcant at P = .05.
bRange of sample size in parentheses.
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Figure 3: Plot of mean pain intensity rating (scale 0–100) during
unloaded movement through full range of motion of the elbow
versus serum 25-hydroxyvitmamin D (25OHD) concentrations
(nmol/L) in female participants (N = 21). Pain rating obtained
2 days after eccentric exercise protocol; 25OHD serum samples
obtained within one week of exercise. Linear regression R-squared
value = 0.07, Pv a l u e = .24. Plot, R-squared, and P value are
representativeofotherpainandmusclestrengthvariablesexamined
in both sexes.
are associated with variations in muscle strength [20, 24, 25].
Nostudy hasyetinvestigated theinterplayinmusclebetween
vitamin D status and VDR variants. It is possible that indi-
viduals with certain VDR genotypes may be more sensitive
to vitamin D insuﬃciency or may respond diﬀerently to
supplementationasisthecaseinbone[26]andpr ostate[27].
Heaney has written extensively on the threshold eﬀect
of vitamin D in intestinal calcium absorption and calcium
homeostasis outcomes; results from these studies put the
threshold concentration of serum 25(OH)D at ∼80nmol/L
[28]. In contrast, Bischoﬀ-Ferrari et al. based a vitamin D
threshold estimate on the risk of falls and fractures, which
partly reﬂects muscle function. This inquiry put the thresh-
old concentration of serum 25(OH)D at ∼40nmol/L [29].
Two recent studies investigating the association between
vitamin D status and muscle strength in young girls also
support a lower threshold for muscle function outcomes.
Foo et al. [30] found greater handgrip strength in girls
with lower serum 25(OH)D concentrations, and Ward et al.
[31] reported that vitamin D status was positively associated
with lower body muscle power and force in adolescent
girls. The mean serum 25(OH)D concentrations were 34
and 21nmol/L, respectively, for the cohorts in these studies,
in contrast to ∼77nmol/L for our participants. If the
threshold for improvement in muscle function is indeed
near 40nmol/L, the association of improved muscle strength
and serum 25(OH)D would only be observed in groups
with poorer status. Further investigation of the vitamin D
threshold eﬀect as it pertains to mechanisms of hypertrophy
following exercise training is required; and indeed, it may
point to improved response to therapeutic exercise by
patients from populations at greatest risk for vitamin D
deﬁciency, especially those with darker-pigmented skin or
those who are not given regular access to sunlight (e.g.,
hospitalized inpatients or nursing home residents).
Although there is a clear link between low vitamin D
status and the pain of osteomalacia, there are no data
availableforaroleofvitaminDinthedelayedpainassociated
with eccentricexercise. Inourstudy, the only knownattempt
to link the two, participants’ ratings of pain intensity and
unpleasantness were collected during unloaded movement;
our results showed that serum 25(OH)D concentrations did
not predict either of the pain measurements.
Despite our belief that vitamin D status would be
negatively associated with muscle pain and weakness, it
is possible that a positive relationship exists. At least
some of the ensuing pain following eccentric exercise is
thought to be caused by an inﬂammatory response which
is essential for muscle tissue remodeling and hypertrophyJournal of Nutrition and Metabolism 5
[32]. This inﬂammatory response is quite similar to the
initial nonspeciﬁc immune response to microbial challenge
[33, 34].In its immunomodulatory role, vitamin D enhances
this portion of the immune response [35]. It is therefore
conceivable that adequate vitamin D status may support a
robust inﬂammatory response to eccentric exercise and thus
contribute to a high level of delayed soreness. Furthermore,
the active form of vitamin D, 1,25(OH)2D, inﬂuences the
diﬀerentiation and proliferation of muscle cells [5]. When
those actions are considered along with encouragement of
the nonspeciﬁc immune response, it appears possible that
postexercise hypertrophy could indeed be improved with
adequate vitamin D. The logical question, consequently,
is what serum 25(OH)D concentration is adequate for
an optimal postexercise inﬂammatory response? Just as
discussed for the muscle strength outcomes, it may be that
the vitamin D threshold for eccentric exercise-associated
pain is relatively low, and which might explain why we did
not see a relationship between vitamin D status and pain
ratings in our participants.
The main limitation of this study is that it involves a
secondary dataanalysis. The exclusioncriteriaoftheprimary
analysis disallowed anyone with pre-existing pain or muscle
disease so it is conceivable that individuals with muscle pain
due to hypovitaminosis D would not be included in our
sample and may have restricted (especially at the lower end)
the range of serum 25(OH)D concentrations observed for
participants in our study. We assumed that serum 25(OH)D
remained fairly stable throughout the 6-day intervention as
it has a serum half-life of ∼3 weeks [36]. This assumption
may be invalid in the unlikely event that a participant
spent a day in the sun after the second day; however, the
eﬀect of this event—ifit occurred—can be considered rather
inconsequential as it takes at least four days to obtain 80%
photoconversion of dermal precursors to vitamin D3 and
even longer to aﬀect 25(OH)D concentrations [37].
In conclusion, our data indicates that vitamin D status
does not predict outcomes of muscle pain and weakness in
young, healthy volunteers after eccentric exercise. Whether
thethreshold eﬀectofvitamin Din the muscleorsome other
factorcanexplainourobservedlackofassociationremainsto
be elucidated. Regardless, further investigations into exercise
training processes are necessary to yield insight into the
plausible relationship between vitamin D status and the
changes in the beneﬁts and risks of resistance training. There
arenumerousresearchgroupsinvestigatingthephenomenon
of exercise-induced muscle damage; serum 25OHD assays
could be easily included to yield insight into the eﬀects of
vitamin D status within those contexts.
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